Acromegaly
Showing 51 - 75 of 166
Acromegaly, Pituitary Gigantism Trial in Japan (Pasireotide LAR)
Completed
- Acromegaly
- Pituitary Gigantism
- Pasireotide LAR
-
Nagoya, Aichi, Japan
- +26 more
Aug 12, 2019
Acromegaly Trial in Le Kremlin-Bicêtre (Performed 3 diagnostic tests (2 OGTT tests with 75 g of Glucose and 1 test with 375 mg
Not yet recruiting
- Acromegaly
- Performed 3 diagnostic tests (2 OGTT tests with 75 g of Glucose and 1 placebo test with 375 mg of Aspartam
- Performed 2 diagnostic tests (2 OGTT tests with 75g of Glucose)
-
Le Kremlin-Bicêtre, FranceAP-HP, Bicêtre Hospital
Aug 21, 2019
IGF-I and Free Fatty Acids Isn Glucose Metabolism in Acromegaly
Completed
- Acromegaly
-
Bucharest, Romania"C. I. Parhon" Institute of Endocrinology
Aug 20, 2019
Acromegaly & Sleep Apnoea
Completed
- Acromegaly
-
Leeds, West Yorkshire, United KingdomLeeds Teaching Hospitals NHS Trust
Aug 16, 2019
Acromegaly Trial in Westmead (Lanreotide (Autogel formulation))
Completed
- Acromegaly
- Lanreotide (Autogel formulation)
-
Westmead, New South Wales, AustraliaWestmead Hospital
Aug 14, 2019
Lanreotide Autogel 120 mg at Extended Dosing Intervals in
Completed
- Acromegaly
-
Lisboa, Portugal
- +38 more
Aug 1, 2019
Acromegaly Trial in Mexico City (lanreotide (Autogel formulation))
Withdrawn
- Acromegaly
- lanreotide (Autogel formulation)
-
Mexico City, MexicoCentro Médico Nacional Siglo XXI, IMSS
Aug 1, 2019
Description of Sign-and-symptom Associations at Acromegaly
Completed
- Acromegaly
-
Amiens, France
- +24 more
Aug 1, 2019
Acromegaly Trial in United Kingdom (Lanreotide (Autogel formulation))
Completed
- Acromegaly
- Lanreotide (Autogel formulation)
-
Hull, East Yorkshire, United Kingdom
- +9 more
Aug 1, 2019
DevelopingHeart Condition Called Valvular Regurgitation in
Completed
- Acromegaly
-
Bruxelles, Belgium
- +32 more
Aug 1, 2019
Acromegaly Trial in Worldwide (Lanreotide (Autogel formulation))
Completed
- Acromegaly
- Lanreotide (Autogel formulation)
-
Birmingham, Alabama
- +28 more
Aug 1, 2019
Acromegaly, Type 2 Diabetes Trial in Los Angeles (Oral Glucose Tolerance Test, Subcutaneous administration of recombinant human
Completed
- Acromegaly
- Type 2 Diabetes Mellitus
- Oral Glucose Tolerance Test
- +2 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center Pituitary Center
Jul 7, 2019
Cushing's Disease, Acromegaly Trial in Worldwide (Pasireotide s.c., Sitagliptin, Liraglutide)
Completed
- Cushing's Disease
- Acromegaly
- Pasireotide s.c.
- +5 more
-
Multiple Locations, California
- +42 more
May 7, 2019
Acromegaly Trial in Le Kremlin Bicêtre (device, drug, procedure)
Completed
- Acromegaly
- CMRI
- +2 more
-
Le Kremlin Bicêtre, FranceAP-HP, Bicêtre Hospital
May 14, 2019
Muscle in Acromegaly and Cushing's Syndrome
Unknown status
- Cushing Syndrome
- Acromegaly
- MRI, dual-energy, x-ray absorptiometry, muscle ultrasounds, blood testing
-
Barcelona, Please Select, SpainHospital de la Santa Creu i Sant Pau
Feb 22, 2019
Acromegaly Trial in China (Lanreotide Autogel®, Lanreotide Acetate)
Completed
- Acromegaly
- Lanreotide Autogel®
- Lanreotide Acetate
-
Beijing, China
- +9 more
Jan 25, 2019
Acromegaly Trial in Worldwide (Lanreotide Autogel 120 mg)
Completed
- Acromegaly
- Lanreotide Autogel 120 mg
-
Rio de Janeiro, Brazil
- +43 more
Jan 10, 2019
Acromegaly Trial in Italy (lanreotide (Autogel formulation), duration of treatment 46-48 weeks)
Completed
- Acromegaly
- lanreotide (Autogel formulation), duration of treatment 46-48 weeks
-
Bergamo, Italy
- +23 more
Jan 11, 2019